Table 2 presents the correlation between TMUB1 expression and the clinicopathological features analysed using logistic regression. High TMUB1 expression was associated with a high risk ratio in M-stage COAD (odds ratio (OR) = 2.082 [1.210–3.675], P = 0.009), clinicopathological advanced stage (OR = 1.487 [1.029–2.153], P = 0.035), and lymphatic metastasis. This evidence concerns the gene TMUB1 and colon adenocarcinoma.